This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Katano, K. Articles by Yagami, Y. Search for Related Content PubMed PubMed Citation Articles by Katano, K. Articles by Yagami, Y. Social Bookmarking                         What's this?

Specific antiphospholipid antibodies (aPL) eluted from placentae of pregnant women with aPL-positive sera

Department of Obstetrics and Gynecology, Nagoya City University Medical School, Mizuho-ku, Nagoya, 467, Japan

K. Aoki

Department of Obstetrics and Gynecology, Nagoya City University Medical School, Mizuho-ku, Nagoya, 467, Japan

M. Ogasawara

Department of Obstetrics and Gynecology, Nagoya City University Medical School, Mizuho-ku, Nagoya, 467, Japan

H. Sasa

Department of Obstetrics and Gynecology, Nagoya City University Medical School, Mizuho-ku, Nagoya, 467, Japan

Y. Hayashi

Department of Obstetrics and Gynecology, Nagoya City University Medical School, Mizuho-ku, Nagoya, 467, Japan

M. Kawamura

Department of Obstetrics and Gynecology, Nagoya City University Medical School, Mizuho-ku, Nagoya, 467, Japan

Y. Yagami

Department of Obstetrics and Gynecology, Nagoya City University Medical School, Mizuho-ku, Nagoya, 467, Japan

The mechanism by which antiphospholipid antibodies (aPL) cause recurrent pregnancy loss remains unclear. It has however been reported that aPL may affect cytotrophoblasts in vitro and thus direct placental damage might occur. Therefore, we investigated whether aPL are bound directly to placental tissues in patients with immunoglobulin G (IgG) -aPL positive sera.

The material investigated comprised the placentae of six patients with a history of recurrent pregnancy loss and subclinical autoimmune disorder and one with systemic lupus erythematosus, who were treated with a combination of prednisolone and aspirin. Normal controls consisted of placentae derived from six women, negative for serum aPL, with no medical or obstetrical complication during their pregnancy.

Five kinds of IgG- and IgM-antiphospholipid (anti-PS, PI, PA, PG and CL) antibodies were eluted from the placentae of both patients and controls, which were measured by enzyme-linked immunosorbent assay.

IgG-aPL were detected in the placental eluates of four of seven (57%) patients, whereas IgM-aPL were not found in any. With respect to the pregnancy outcome of the four patients with IgG-aPL-positive placental eluates, one experienced intrauterine fetal death (IUFD) at 23 weeks of gestation and three demonstrated intrauterine growth retardation (IUGR). In contrast, the remaining three patients, evaluated negative for IgG-aPL in placental eluates, gave birth to one baby with IUGR and two appropriate-for-date babies. The placentae of the four mothers with IgG-aPL-positive placental eluates pathologically showed severe thrombotic findings.

These results suggest that IgG-aPL can directly bind to placental tissue and might cause pathologic damage resulting in IUFD or IUGR.

Key Words: antiphospholipid antibodies • placental elution • recurrent pregnancy loss

Lupus, Vol. 4, No. 4, 304-308 (1995)
DOI: 10.1177/096120339500400412


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S Donohoe, J C P Kingdom, and I J Mackie Affinity purified human antiphospholipid antibodies bind normal term placenta Lupus, September 1, 1999; 8(7): 525 - 531. [Abstract] [PDF]

				M.D. Lockshin Review : Pregnancy loss and antiphospholipid antibodies Lupus, January 1, 1998; 7(2_suppl): S86 - S89. [Abstract] [PDF]

				L. Lakasing and L. Poston Adverse pregnancy outcome in the antiphospholipid syndrome: focus for future research Lupus, January 1, 1997; 6(9): 681 - 684. [Abstract] [PDF]